VANCOUVER, British Columbia / May 07, 2025 / Business Wire / WELL Health Technologies Corp. (TSX:WELL, OTCQX:WHTCF) (“WELL” or the “Company”) a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. (“WELLSTAR”), Canada’s leading provider of interoperable technology solutions for healthcare providers, has launched Nexus AI™—a groundbreaking, Canadian-built artificial intelligence platform that seamlessly integrates with popular Canadian EMR systems.
Nexus AI streamlines clinical workflows while reducing healthcare providers' administrative burden and cognitive load. The platform's first feature, an AI medical scribe, enables real-time clinical documentation across care settings. It automatically documents patient encounters and prepares draft notes, offering customized templates for each provider's specialty and unique documentation style.
The underlying AI technology powering Nexus AI has been developed by a multidisciplinary team of physicians and AI researchers from the University of Toronto and is commercialized by WELL’s subsidiary HEALWELL AI. Through WELLSTAR’s strategic relationship with HEALWELL, this proven technology is now integrated into Nexus AI and made widely available to Canadian healthcare providers. It is actively used by thousands of primary care and specialist physicians in communities, hospitals and regional health authorities across Canada, bringing proven performance in clinical environments.
“We are extremely excited to be launching this transformative AI platform - Nexus AI. This is a foundational part of our strategy to bring the latest AI innovations to healthcare providers in a way that is seamlessly integrated into their workflows,” commented Amir Javidan, CEO, WELLSTAR Technologies Corp. “WELLSTAR has established the largest ecosystem of digital health technology applications in Canada, creating an environment that enables partners to build AI tools that prioritize the provider experience collaboratively.”
Nexus AI is purpose-built for compatibility across Canada's diverse EMR landscape and continues to be developed in close partnerships with leading EMRs across Canada to provide deeper automation of tasks for providers. Starting with best-in-class ambient scribe capabilities, Nexus AI will serve as the hub for expanding automated AI and agentic features, including disease detection for rare and chronic care conditions, medical coding, billing automation, and other clinical decision support. This positions WELLSTAR at the forefront of delivering intelligent, integrated solutions to Canadian healthcare providers.
The platform is fully hosted and operated in Canada, which aligns with WELLSTAR’s commitment to data residency and sovereignty. Built with enterprise-grade security, Nexus AI is currently being deployed across a wide range of clinics and hospitals nationwide.
Nexus AI is participating in Canada Health Infoway’s AI Scribe Program. This important national initiative will fund one-year licenses for AI scribes for up to 10,000 eligible primary care clinicians, providing early adopters access to tools that help improve documentation processes and streamline workflows.
Providers and clinicians interested in accessing Nexus AI can visit: https://nexusai.wellhealth.ai.
WELL HEALTH TECHNOLOGIES CORP.
Per: "Hamed Shahbazi"
Hamed Shahbazi
Chief Executive Officer, Chairman and Director
About WELL Health Technologies Corp.
WELL’s mission is to tech-enable healthcare providers. We do this by developing the best technologies, services, and support available, which ensures healthcare providers are empowered to positively impact patient outcomes. WELL’s comprehensive healthcare and digital platform includes extensive front and back-office management software applications that help physicians run and secure their practices. WELL’s solutions enable more than 41,000 healthcare providers between the US and Canada and power the largest owned and operated healthcare ecosystem in Canada with more than 200 clinics supporting primary care, specialized care, and diagnostic services. In the United States WELL’s solutions are focused on specialized markets such as the gastrointestinal market, women's health, primary care, and mental health. WELL is publicly traded on the Toronto Stock Exchange under the symbol “WELL” and on the OTC Exchange under the symbol “WHTCF”. To learn more about the Company, please visit: www.well.company.
About WELLSTAR Technologies Corp.
WELLSTAR Technologies supports Canada’s healthcare providers with our extensive expertise in healthcare technology, clinic operations, and digital transformation. As part of WELL Health, which operates over 200 healthcare clinics and supports over 41,000 providers across Canada, we bring deep industry knowledge and a proven track record of optimizing clinical workflows, enhancing patient engagement, and streamlining administrative processes. With a comprehensive suite of technology solutions, we have successfully helped thousands of providers adopt and benefit from modern, interoperable technologies that improve patient outcomes and system efficiency. To learn more about WELLSTAR, please visit https://wellstar.health.
Last Trade: | C$3.89 |
Daily Change: | 0.09 2.37 |
Daily Volume: | 932,975 |
Market Cap: | C$968.450M |
April 15, 2025 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load